GSK will launch the first tetravalent flu vaccine ‘Fluarix Tetra’

GSK announced that it would launch the first domestic tetravalent influenza vaccine ‘Fluarix Tetra’.

Fluatrix Tetra includes 2 types of virus type A (A/H1N1, A.H3N2) and 2 types of virus type B (B-Victoria, B-Yamagata), causing influenza for both infants over 3 and adults.

Including Korea, it is approved in 22 different countries, such as the U.S., the U.K., Germany, France, Spain, Switzerlan...